CRABP1 and neoplasm: Similar to CRBPs, CRABP1 has been implicated in tumour suppression, with studies showing that its mRNA levels are reduced in certain human epithelial tumours (colorectal and hepatocellular cancers) due to hypermethylation of its promoter region (Table 3) [55,56].